microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
Authors
Keywords
-
Journal
Oncology Letters
Volume 7, Issue 1, Pages 183-188
Publisher
Spandidos Publications
Online
2013-10-29
DOI
10.3892/ol.2013.1644
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
- (2012) Xin Fu et al. FEBS LETTERS
- Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance
- (2012) LINGYUN YANG et al. ONCOLOGY REPORTS
- MicroRNAs, stem cells and cancer stem cells
- (2012) Minal Garg World Journal of Stem Cells
- Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
- (2011) R. Hamano et al. CLINICAL CANCER RESEARCH
- Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma Cells
- (2011) Richard Hummel et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: single or combination chemotherapy?
- (2010) G Adams et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells
- (2010) Jipeng Li et al. BMC CANCER
- MicroRNAs and Metastasis: Little RNAs Go a Long Way
- (2010) D. M. Dykxhoorn CANCER RESEARCH
- Targeting the p53 Pathway of Apoptosis
- (2010) Joana D. Amaral et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer
- (2010) Lori E. Weinberg et al. JOURNAL OF SURGICAL ONCOLOGY
- Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer
- (2010) Åsa Ehlén et al. Journal of Translational Medicine
- MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines
- (2010) Zhi-wei Yu et al. ORAL ONCOLOGY
- Micromanipulating cancer: microRNA-based therapeutics?
- (2010) Fabio Petrocca et al. RNA Biology
- PDCD4 inhibits the malignant phenotype of ovarian cancer cells
- (2009) Zeng-Tao Wei et al. CANCER SCIENCE
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy
- (2009) Todd Boren et al. GYNECOLOGIC ONCOLOGY
- MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
- (2009) T. Moriyama et al. MOLECULAR CANCER THERAPEUTICS
- Role of microRNAs in drug-resistant ovarian cancer cells
- (2008) Antonio Sorrentino et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now